Dow Up 0.08% Nasdaq Down 0.30%

Puma Biotechnology, Inc. (PBYI)

-NYSE
270.32 Down 4.75(1.73%) Sep 19, 4:01PM EDT
|After Hours : 270.32 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:275.07
Open:276.71
Bid:262.52 x 100
Ask:270.50 x 100
1y Target Est:305.67
Beta:-2.89
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:265.10 - 278.14
52wk Range:33.70 - 279.37
Volume:704,289
Avg Vol (3m):564,711
Market Cap:8.14B
P/E (ttm):N/A
EPS (ttm):-2.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.01
Quarterly EPS Est (Sep-14) :-1.21
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products to enhance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback